These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11731524)

  • 1. Letrozole in second-line therapy of advanced breast cancer: more questions than answers.
    Mackey JR; Joy AA
    J Clin Oncol; 2001 Dec; 19(23):4353-5. PubMed ID: 11731524
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate.
    Buzdar A; Douma J; Davidson N; Elledge R; Morgan M; Smith R; Porter L; Nabholtz J; Xiang X; Brady C
    J Clin Oncol; 2001 Jul; 19(14):3357-66. PubMed ID: 11454883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.
    Dombernowsky P; Smith I; Falkson G; Leonard R; Panasci L; Bellmunt J; Bezwoda W; Gardin G; Gudgeon A; Morgan M; Fornasiero A; Hoffmann W; Michel J; Hatschek T; Tjabbes T; Chaudri HA; Hornberger U; Trunet PF
    J Clin Oncol; 1998 Feb; 16(2):453-61. PubMed ID: 9469328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials.
    Carlini P; Bria E; Giannarelli D; Ferretti G; Felici A; Papaldo P; Fabi A; Nisticò C; Di Cosimo S; Ruggeri EM; Milella M; Mottolese M; Terzoli E; Cognetti F
    Cancer; 2005 Oct; 104(7):1335-42. PubMed ID: 16088965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer survivors.
    Boyle F; Forbes J
    Aust Fam Physician; 2008 Oct; 37(10):791. PubMed ID: 19013826
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer.
    Bertelli G; Garrone O; Merlano M; Occelli M; Bertolotti L; Castiglione F; Pepi F; Fusco O; Del Mastro L; Leonard RC
    Oncology; 2005; 69(6):471-7. PubMed ID: 16410685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer.
    Robertson JF; Howell A; Buzdar A; von Euler M; Lee D
    Breast Cancer Res Treat; 1999 Nov; 58(2):157-62. PubMed ID: 10674881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea.
    Beom SH; Oh J; Kim TY; Lee KH; Yang Y; Suh KJ; Moon HG; Han SW; Oh DY; Han W; Kim TY; Noh DY; Im SA
    Cancer Res Treat; 2017 Apr; 49(2):454-463. PubMed ID: 27554482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase inhibitors for therapy of advanced breast cancer.
    Ingle JN; Suman VJ
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):113-9. PubMed ID: 15939585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer.
    Dunn C; Keam SJ
    Pharmacoeconomics; 2006; 24(5):495-517. PubMed ID: 16706574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of letrozole in postmenopausal women with hormone-responsive breast cancer.
    Barnadas A; Estévez LG; Lluch-Hernández A; Rodriguez-Lescure A; Rodriguez-Sanchez C; Sanchez-Rovira P
    Adv Ther; 2011 Dec; 28(12):1045-58. PubMed ID: 22068628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?
    Kaufmann M; Rody A
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):146-54. PubMed ID: 16621229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letrozole: a review of its use in postmenopausal women with breast cancer.
    Simpson D; Curran MP; Perry CM
    Drugs; 2004; 64(11):1213-30. PubMed ID: 15161328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letrozole for the treatment of pretreated advanced breast cancer patients: preliminary report.
    Casali A; Sega FM; Casali M; Giuntini T; Cappellini GC; Terzoli E
    J Exp Clin Cancer Res; 2000 Mar; 19(1):17-9. PubMed ID: 10840931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CGS20267 (Letrozole), a new aromatase inhibitor: late phase II study in postmenopausal women with advanced or recurrent breast cancer (no. 2)--evaluation of efficacy and safety at the recommended clinical dose CGS20267 Study Group].
    Kimijima I; Tominaga T; Nomizu T; Nomura Y; Takashima S; Koyama H; Sano M; Tohge T; Ueo H; Ikeda S; Ohashi Y;
    Gan To Kagaku Ryoho; 2002 May; 29(5):741-9. PubMed ID: 12040678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group].
    Illiger HJ
    Strahlenther Onkol; 2002 Feb; 178(2):111-3. PubMed ID: 11942036
    [No Abstract]   [Full Text] [Related]  

  • 17. False shortening of time to progression in letrozole 2.5-mg dose?
    Cocconi G
    J Clin Oncol; 2001 Dec; 19(23):4353; author reply 4354-5. PubMed ID: 11731525
    [No Abstract]   [Full Text] [Related]  

  • 18. Pivotal trials of letrozole: a new aromatase inhibitor.
    Smith IE
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):41-4. PubMed ID: 9556791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anastrozole. A review of its use in the management of postmenopausal women with advanced breast cancer.
    Wiseman LR; Adkins JC
    Drugs Aging; 1998 Oct; 13(4):321-32. PubMed ID: 9805213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
    Cohen MH; Johnson JR; Li N; Chen G; Pazdur R
    Clin Cancer Res; 2002 Mar; 8(3):665-9. PubMed ID: 11895893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.